Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences|February 22, 2014
Contrast staining on CT after DSA in ischemic stroke patients progresses to infarction and rarely hemorrhagesMatthew R Amans, Daniel L Cooke, Maya Vella, et al.
Radiology|June 14, 2014
Idiopathic pulmonary fibrosis: CT and risk of deathBrett Ley, Brett M Elicker, Thomas E Hartman, et al.
The European Respiratory Journal|December 11, 2012
Prevalence and prognosis of unclassifiable interstitial lung diseaseChristopher J Ryerson, Thomas H Urbania, Luca Richeldi, et al.
Annals of Internal Medicine|May 16, 2012
A multidimensional index and staging system for idiopathic pulmonary fibrosisBrett Ley, Christopher J Ryerson, Eric Vittinghoff, et al.
Thorax|March 20, 2012
Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosisLuca Richeldi, Christopher J Ryerson, Joyce S Lee, et al.
Chest|October 12, 2013
Predicting survival across chronic interstitial lung disease: the ILD-GAP modelChristopher J Ryerson, Eric Vittinghoff, Brett Ley, et al.
The Lancet. Respiratory Medicine|June 27, 2017
The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control studyBrett Ley, Chad A Newton, Isabel Arnould, et al.
Respiratory Medicine|August 26, 2015
Survival in interstitial pneumonia with features of autoimmune disease: a comparison of proposed criteriaDeborah Assayag, Eunice J Kim, Brett M Elicker, et al.
Chest|November 7, 2016
Use of Mycophenolate Mofetil or Azathioprine for the Management of Chronic Hypersensitivity PneumonitisJulie Morisset, Kerri A Johannson, Eric Vittinghoff, et al.
Respiratory Research|November 22, 2012
Cleaved cytokeratin-18 is a mechanistically informative biomarker in idiopathic pulmonary fibrosisSeung-Ick Cha, Christopher J Ryerson, Joyce S Lee, et al.
Pageof 9